From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

AstraZeneca PLC

www.astrazeneca.com

Most Recent Related Deals

Teva can market its budenoside under settlement with AZ, 5/2010
AZ and the TB Alliance join forces, 5/2010
AZ takes on 18 of Torrent's branded generics, 3/2010
AstraZeneca, UPenn partner for tau-mediated Alzheimer's , 3/2010
MedImmune licenses peptides from Xenome, 3/2010
AZ pays $100mm up front for rights to Rigel's RA candidate, 2/2010
Teva and AZ settle litigation surrounding two reflux drugs, 1/2010
Dako and AZ to develop companion diagnostics for cancer , 1/2010
MedImmune licenses rights to Trellis's RSV antibodies, 12/2009
AZ pays $200mm up front for rights to Targacept's TC5214, 12/2009

Most Recent Related Articles

Click an article to see a free preview (15 of 526).

Celgene Moves Into Solid Tumors With $2.9 Billion Abraxis Acquisition , Start-Up 7/2010
AstraZeneca's Motavizumab May Be The Canary In The Follow-On Coal Mine, Start-Up 7/2010
FDA Opens Up: Can Industry Live With Greater Transparency?, Medtech Insight 7/2010
FDA Opens Up: Can Industry Live With Greater Transparency?, Start-Up 7/2010
Deals Of The Week: Grifols/Talecris, Sanofi/Vivalis, Forest/TransTech ..., The Pink Sheet 6/2010
Deals of the Week Screams ¡GOOOOOOOOOLLLLLLL!, The IN VIVO Blog 6/2010
Best Of The IN VIVO Blog (06/2010), Start-Up 6/2010
With Pharma Ready to Pare Portfolios, Project Financing Funds Make Their Pitches, Start-Up 6/2010
Astellas Wins OSI But Victory Comes At A Price, Start-Up 6/2010
Altering The Insulin Resistance System, In Vivo 6/2010
Genentech's New Deal Maker, In Vivo 6/2010
TetraPhase's Series C, In Vivo 6/2010
TB Drug Development: An Attractive Public Health Project for FDA, Medtech Insight 5/2010
AZ and Merck: Moving Forward Cautiously , Start-Up 5/2010
Biopharma Quarterly Statistics Q1 2010, Start-Up 5/2010

See all 526 articles about this company

Copyright © 2009 Elsevier Inc. All rights reserved. Elsevier Business Intelligence, www.ElsevierBI.com.
Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com.